Latest News

14 June 2019

Moral Emotions, a Diagnostic Tool for Frontotemporal Dementia?

A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris, France and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia (FTD). The results, published in the Journal of Alzheimer’s Disease, open a new approach for early, sensitive and specific diagnosis of FTD.

12 June 2019

Specific Multinutrient Combination Benefits Patients with Early Stage Alzheimer’s Disease

A new longitudinal study has shown that a nutritional drink* designated a "food for special medical purposes" containing the multinutrient combination Fortasyn Connect® can benefit patients with the earliest stages of Alzheimer's disease (AD), mild cognitive impairment, who are at risk of progressing to the dementia stage of AD, report scientists in the Journal of Alzheimer's Disease Reports.

11 June 2019

Opioid Analgesics Increase the Risk of Pneumonia Among Persons with Alzheimer's Disease

Opioid analgesics were associated with a 30% increase in the risk of pneumonia in persons with Alzheimer’s disease, a recent study from the University of Eastern Finland shows. The risk was most pronounced in the first two months of use. This is the first study to investigate the association between opioids and pneumonia in this population. The results were published in the Journal of Alzheimer’s Disease.

3 June 2019

Antihypertensive Drug Use Associated with a Decreased Dementia Risk in Almost 25,000 Elderly Persons Followed in General Practices in Germany

Drs. Jacob, Bohlken, & Kostev

Various clinical trials indicate what effects can be expected from standardized intervention programs on the basis of existing evidence. Little is known about the way in which such programs can be implemented in actual care practice. However, it may be possible to use data from clinical practice to estimate the potential of drug prescriptions to delay or reduce the development of dementia. The goal of the present study was to investigate the relationship between antihypertensive drug use and dementia in elderly persons followed in general practices in Germany.

26 March 2019

Study Published in Journal of Alzheimer's Disease Finds No Causal Link Between Smoking and Dementia

Erin Abner

It's an irrefutable fact that smoking is bad for you. Study after study has proven that smoking increases your risk for cancer, heart disease, diabetes – even blindness. But dementia? Not so fast. A recent study has demonstrated that smoking is not associated with a higher risk of dementia. Many previous studies have found a correlation between smoking and dementia. However, Erin Abner of the University of Kentucky's Sanders-Brown Center on Aging (SBCoA) and colleagues wanted to explore outcomes using a different method of data analysis.

28 January 2019

In Life and Death, Alzheimer’s Disease Looks Different among Hispanic Patients

Researchers at Shiley-Marcos Alzheimer’s Disease Research Center (ADRC), part of University of California San Diego School of Medicine, report that autopsies of patients diagnosed with Alzheimer’s disease (AD) when they were alive – and confirmed by autopsy – indicate many cognitive issues symptomatic of the condition are less noticeable in living Hispanic patients.

17 January 2019

Psychological Distress is a Risk Factor for Dementia: Results from a Danish Population-Based Study

A new study suggests that vital exhaustion, which can be perceived as an indicator of psychological distress, is a risk factor for future risk of dementia. Researchers from the Department of Public Health, University of Copenhagen have, in collaboration with the National Research Centre for the Working Environment, and the Danish Dementia Research Centre, shown that being distressed in late midlife is associated with a higher risk of dementia in later life.

Pages

Subscribe to Latest News